March 11, 2020 / 9:15 PM / a month ago

BRIEF-MiRagen Posts Quarterly Loss Per Share Of $0.31

March 11 (Reuters) - miRagen Therapeutics Inc:

* MIRAGEN REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.31

* Q4 REVENUE $900,000 VERSUS REFINITIV IBES ESTIMATE OF $723,000

* Q4 EARNINGS PER SHARE ESTIMATE $-0.25 — REFINITIV IBES DATA

* MIRAGEN - BELIEVES THAT ITS CURRENT CASH, CASH EQUIVALENTS AND SHORT TERM INVESTMENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO Q3 OF 2021

* QTRLY NET LOSS $0.31 PER SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below